カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の3Dプリンター製医薬品市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global 3D Printing Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19089）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19089
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：76
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の3Dプリンター製医薬品市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

3Dプリンター製医薬品市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の3Dプリンター製医薬品の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

3Dプリンター製医薬品市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ZipDose、MED、FDM、SSE、その他

用途別セグメントは次のように区分されます。
・経口固形剤、非経口固形剤、その他

世界の3Dプリンター製医薬品市場の主要な市場プレーヤーは以下のとおりです。
・Aprecia Pharmaceuticals、Triastek、FabRx、Multiply Labs

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、3Dプリンター製医薬品製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な3Dプリンター製医薬品メーカーの企業概要、2019年～2022年までの3Dプリンター製医薬品の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な3Dプリンター製医薬品メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別3Dプリンター製医薬品の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの3Dプリンター製医薬品の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での3Dプリンター製医薬品市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および3Dプリンター製医薬品の産業チェーンを掲載しています。
・第13、14、15章では、3Dプリンター製医薬品の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 3Dプリンター製医薬品の概要
- 種類別分析（2017年vs2021年vs2028年）：ZipDose、MED、FDM、SSE、その他
- 用途別分析（2017年vs2021年vs2028年）：経口固形剤、非経口固形剤、その他
- 世界の3Dプリンター製医薬品市場規模・予測
- 世界の3Dプリンター製医薬品生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Aprecia Pharmaceuticals、Triastek、FabRx、Multiply Labs
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ZipDose、MED、FDM、SSE、その他
・用途別分析2017年-2028年：経口固形剤、非経口固形剤、その他
・3Dプリンター製医薬品の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・3Dプリンター製医薬品のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・3Dプリンター製医薬品のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・3Dプリンター製医薬品の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・3Dプリンター製医薬品の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The 3D Printing Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global 3D Printing Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Oral Solid Dosage Form accounting for % of the 3D Printing Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While ZipDose segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of 3D Printing Drug include Aprecia Pharmaceuticals, Triastek, FabRx, Multiply Labs, and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
3D Printing Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
ZipDose
MED
FDM
SSE
Other
Market segment by Application can be divided into
Oral Solid Dosage Form
Non-Oral Solid Dosage Form
Other
The key market players for global 3D Printing Drug market are listed below:
Aprecia Pharmaceuticals
Triastek
FabRx
Multiply Labs
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe 3D Printing Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of 3D Printing Drug, with price, sales, revenue and global market share of 3D Printing Drug from 2019 to 2022.
Chapter 3, the 3D Printing Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the 3D Printing Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and 3D Printing Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of 3D Printing Drug.
Chapter 13, 14, and 15, to describe 3D Printing Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 3D Printing Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global 3D Printing Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 ZipDose
1.2.3 MED
1.2.4 FDM
1.2.5 SSE
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global 3D Printing Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oral Solid Dosage Form
1.3.3 Non-Oral Solid Dosage Form
1.3.4 Other
1.4 Global 3D Printing Drug Market Size & Forecast
1.4.1 Global 3D Printing Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global 3D Printing Drug Sales in Volume (2017-2028)
1.4.3 Global 3D Printing Drug Price (2017-2028)
1.5 Global 3D Printing Drug Production Capacity Analysis
1.5.1 Global 3D Printing Drug Total Production Capacity (2017-2028)
1.5.2 Global 3D Printing Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 3D Printing Drug Market Drivers
1.6.2 3D Printing Drug Market Restraints
1.6.3 3D Printing Drug Trends Analysis
2 Manufacturers Profiles
2.1 Aprecia Pharmaceuticals
2.1.1 Aprecia Pharmaceuticals Details
2.1.2 Aprecia Pharmaceuticals Major Business
2.1.3 Aprecia Pharmaceuticals 3D Printing Drug Product and Services
2.1.4 Aprecia Pharmaceuticals 3D Printing Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Triastek
2.2.1 Triastek Details
2.2.2 Triastek Major Business
2.2.3 Triastek 3D Printing Drug Product and Services
2.2.4 Triastek 3D Printing Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 FabRx
2.3.1 FabRx Details
2.3.2 FabRx Major Business
2.3.3 FabRx 3D Printing Drug Product and Services
2.3.4 FabRx 3D Printing Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Multiply Labs
2.4.1 Multiply Labs Details
2.4.2 Multiply Labs Major Business
2.4.3 Multiply Labs 3D Printing Drug Product and Services
2.4.4 Multiply Labs 3D Printing Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 3D Printing Drug Breakdown Data by Manufacturer
3.1 Global 3D Printing Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global 3D Printing Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in 3D Printing Drug
3.4 Market Concentration Rate
3.4.1 Top 3 3D Printing Drug Manufacturer Market Share in 2021
3.4.2 Top 6 3D Printing Drug Manufacturer Market Share in 2021
3.5 Global 3D Printing Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and 3D Printing Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global 3D Printing Drug Market Size by Region
4.1.1 Global 3D Printing Drug Sales in Volume by Region (2017-2028)
4.1.2 Global 3D Printing Drug Revenue by Region (2017-2028)
4.2 North America 3D Printing Drug Revenue (2017-2028)
4.3 Europe 3D Printing Drug Revenue (2017-2028)
4.4 Asia-Pacific 3D Printing Drug Revenue (2017-2028)
4.5 South America 3D Printing Drug Revenue (2017-2028)
4.6 Middle East and Africa 3D Printing Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global 3D Printing Drug Sales in Volume by Type (2017-2028)
5.2 Global 3D Printing Drug Revenue by Type (2017-2028)
5.3 Global 3D Printing Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global 3D Printing Drug Sales in Volume by Application (2017-2028)
6.2 Global 3D Printing Drug Revenue by Application (2017-2028)
6.3 Global 3D Printing Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America 3D Printing Drug Sales by Type (2017-2028)
7.2 North America 3D Printing Drug Sales by Application (2017-2028)
7.3 North America 3D Printing Drug Market Size by Country
7.3.1 North America 3D Printing Drug Sales in Volume by Country (2017-2028)
7.3.2 North America 3D Printing Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe 3D Printing Drug Sales by Type (2017-2028)
8.2 Europe 3D Printing Drug Sales by Application (2017-2028)
8.3 Europe 3D Printing Drug Market Size by Country
8.3.1 Europe 3D Printing Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe 3D Printing Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific 3D Printing Drug Sales by Type (2017-2028)
9.2 Asia-Pacific 3D Printing Drug Sales by Application (2017-2028)
9.3 Asia-Pacific 3D Printing Drug Market Size by Region
9.3.1 Asia-Pacific 3D Printing Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific 3D Printing Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America 3D Printing Drug Sales by Type (2017-2028)
10.2 South America 3D Printing Drug Sales by Application (2017-2028)
10.3 South America 3D Printing Drug Market Size by Country
10.3.1 South America 3D Printing Drug Sales in Volume by Country (2017-2028)
10.3.2 South America 3D Printing Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa 3D Printing Drug Sales by Type (2017-2028)
11.2 Middle East & Africa 3D Printing Drug Sales by Application (2017-2028)
11.3 Middle East & Africa 3D Printing Drug Market Size by Country
11.3.1 Middle East & Africa 3D Printing Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa 3D Printing Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of 3D Printing Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of 3D Printing Drug
12.3 3D Printing Drug Production Process
12.4 3D Printing Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 3D Printing Drug Typical Distributors
13.3 3D Printing Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global 3D Printing Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global 3D Printing Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Aprecia Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Aprecia Pharmaceuticals Major Business
Table 5. Aprecia Pharmaceuticals 3D Printing Drug Product and Services
Table 6. Aprecia Pharmaceuticals 3D Printing Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Triastek Basic Information, Manufacturing Base and Competitors
Table 8. Triastek Major Business
Table 9. Triastek 3D Printing Drug Product and Services
Table 10. Triastek 3D Printing Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. FabRx Basic Information, Manufacturing Base and Competitors
Table 12. FabRx Major Business
Table 13. FabRx 3D Printing Drug Product and Services
Table 14. FabRx 3D Printing Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Multiply Labs Basic Information, Manufacturing Base and Competitors
Table 16. Multiply Labs Major Business
Table 17. Multiply Labs 3D Printing Drug Product and Services
Table 18. Multiply Labs 3D Printing Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Global 3D Printing Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 20. Global 3D Printing Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 21. Market Position of Manufacturers in 3D Printing Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 22. Global 3D Printing Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 23. Head Office and 3D Printing Drug Production Site of Key Manufacturer
Table 24. 3D Printing Drug New Entrant and Capacity Expansion Plans
Table 25. 3D Printing Drug Mergers & Acquisitions in the Past Five Years
Table 26. Global 3D Printing Drug Sales by Region (2017-2022) & (K Units)
Table 27. Global 3D Printing Drug Sales by Region (2023-2028) & (K Units)
Table 28. Global 3D Printing Drug Revenue by Region (2017-2022) & (USD Million)
Table 29. Global 3D Printing Drug Revenue by Region (2023-2028) & (USD Million)
Table 30. Global 3D Printing Drug Sales by Type (2017-2022) & (K Units)
Table 31. Global 3D Printing Drug Sales by Type (2023-2028) & (K Units)
Table 32. Global 3D Printing Drug Revenue by Type (2017-2022) & (USD Million)
Table 33. Global 3D Printing Drug Revenue by Type (2023-2028) & (USD Million)
Table 34. Global 3D Printing Drug Price by Type (2017-2022) & (US$/Unit)
Table 35. Global 3D Printing Drug Price by Type (2023-2028) & (US$/Unit)
Table 36. Global 3D Printing Drug Sales by Application (2017-2022) & (K Units)
Table 37. Global 3D Printing Drug Sales by Application (2023-2028) & (K Units)
Table 38. Global 3D Printing Drug Revenue by Application (2017-2022) & (USD Million)
Table 39. Global 3D Printing Drug Revenue by Application (2023-2028) & (USD Million)
Table 40. Global 3D Printing Drug Price by Application (2017-2022) & (US$/Unit)
Table 41. Global 3D Printing Drug Price by Application (2023-2028) & (US$/Unit)
Table 42. North America 3D Printing Drug Sales by Country (2017-2022) & (K Units)
Table 43. North America 3D Printing Drug Sales by Country (2023-2028) & (K Units)
Table 44. North America 3D Printing Drug Revenue by Country (2017-2022) & (USD Million)
Table 45. North America 3D Printing Drug Revenue by Country (2023-2028) & (USD Million)
Table 46. North America 3D Printing Drug Sales by Type (2017-2022) & (K Units)
Table 47. North America 3D Printing Drug Sales by Type (2023-2028) & (K Units)
Table 48. North America 3D Printing Drug Sales by Application (2017-2022) & (K Units)
Table 49. North America 3D Printing Drug Sales by Application (2023-2028) & (K Units)
Table 50. Europe 3D Printing Drug Sales by Country (2017-2022) & (K Units)
Table 51. Europe 3D Printing Drug Sales by Country (2023-2028) & (K Units)
Table 52. Europe 3D Printing Drug Revenue by Country (2017-2022) & (USD Million)
Table 53. Europe 3D Printing Drug Revenue by Country (2023-2028) & (USD Million)
Table 54. Europe 3D Printing Drug Sales by Type (2017-2022) & (K Units)
Table 55. Europe 3D Printing Drug Sales by Type (2023-2028) & (K Units)
Table 56. Europe 3D Printing Drug Sales by Application (2017-2022) & (K Units)
Table 57. Europe 3D Printing Drug Sales by Application (2023-2028) & (K Units)
Table 58. Asia-Pacific 3D Printing Drug Sales by Region (2017-2022) & (K Units)
Table 59. Asia-Pacific 3D Printing Drug Sales by Region (2023-2028) & (K Units)
Table 60. Asia-Pacific 3D Printing Drug Revenue by Region (2017-2022) & (USD Million)
Table 61. Asia-Pacific 3D Printing Drug Revenue by Region (2023-2028) & (USD Million)
Table 62. Asia-Pacific 3D Printing Drug Sales by Type (2017-2022) & (K Units)
Table 63. Asia-Pacific 3D Printing Drug Sales by Type (2023-2028) & (K Units)
Table 64. Asia-Pacific 3D Printing Drug Sales by Application (2017-2022) & (K Units)
Table 65. Asia-Pacific 3D Printing Drug Sales by Application (2023-2028) & (K Units)
Table 66. South America 3D Printing Drug Sales by Country (2017-2022) & (K Units)
Table 67. South America 3D Printing Drug Sales by Country (2023-2028) & (K Units)
Table 68. South America 3D Printing Drug Revenue by Country (2017-2022) & (USD Million)
Table 69. South America 3D Printing Drug Revenue by Country (2023-2028) & (USD Million)
Table 70. South America 3D Printing Drug Sales by Type (2017-2022) & (K Units)
Table 71. South America 3D Printing Drug Sales by Type (2023-2028) & (K Units)
Table 72. South America 3D Printing Drug Sales by Application (2017-2022) & (K Units)
Table 73. South America 3D Printing Drug Sales by Application (2023-2028) & (K Units)
Table 74. Middle East & Africa 3D Printing Drug Sales by Region (2017-2022) & (K Units)
Table 75. Middle East & Africa 3D Printing Drug Sales by Region (2023-2028) & (K Units)
Table 76. Middle East & Africa 3D Printing Drug Revenue by Region (2017-2022) & (USD Million)
Table 77. Middle East & Africa 3D Printing Drug Revenue by Region (2023-2028) & (USD Million)
Table 78. Middle East & Africa 3D Printing Drug Sales by Type (2017-2022) & (K Units)
Table 79. Middle East & Africa 3D Printing Drug Sales by Type (2023-2028) & (K Units)
Table 80. Middle East & Africa 3D Printing Drug Sales by Application (2017-2022) & (K Units)
Table 81. Middle East & Africa 3D Printing Drug Sales by Application (2023-2028) & (K Units)
Table 82. 3D Printing Drug Raw Material
Table 83. Key Manufacturers of 3D Printing Drug Raw Materials
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. 3D Printing Drug Typical Distributors
Table 87. 3D Printing Drug Typical Customers
List of Figures
Figure 1. 3D Printing Drug Picture
Figure 2. Global 3D Printing Drug Revenue Market Share by Type in 2021
Figure 3. ZipDose
Figure 4. MED
Figure 5. FDM
Figure 6. SSE
Figure 7. Other
Figure 8. Global 3D Printing Drug Revenue Market Share by Application in 2021
Figure 9. Oral Solid Dosage Form
Figure 10. Non-Oral Solid Dosage Form
Figure 11. Other
Figure 12. Global 3D Printing Drug Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global 3D Printing Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global 3D Printing Drug Sales (2017-2028) & (K Units)
Figure 15. Global 3D Printing Drug Price (2017-2028) & (US$/Unit)
Figure 16. Global 3D Printing Drug Production Capacity (2017-2028) & (K Units)
Figure 17. Global 3D Printing Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. 3D Printing Drug Market Drivers
Figure 19. 3D Printing Drug Market Restraints
Figure 20. 3D Printing Drug Market Trends
Figure 21. Global 3D Printing Drug Sales Market Share by Manufacturer in 2021
Figure 22. Global 3D Printing Drug Revenue Market Share by Manufacturer in 2021
Figure 23. 3D Printing Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 3D Printing Drug Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 3D Printing Drug Manufacturer (Revenue) Market Share in 2021
Figure 26. Global 3D Printing Drug Sales Market Share by Region (2017-2028)
Figure 27. Global 3D Printing Drug Revenue Market Share by Region (2017-2028)
Figure 28. North America 3D Printing Drug Revenue (2017-2028) & (USD Million)
Figure 29. Europe 3D Printing Drug Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific 3D Printing Drug Revenue (2017-2028) & (USD Million)
Figure 31. South America 3D Printing Drug Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa 3D Printing Drug Revenue (2017-2028) & (USD Million)
Figure 33. Global 3D Printing Drug Sales Market Share by Type (2017-2028)
Figure 34. Global 3D Printing Drug Revenue Market Share by Type (2017-2028)
Figure 35. Global 3D Printing Drug Price by Type (2017-2028) & (US$/Unit)
Figure 36. Global 3D Printing Drug Sales Market Share by Application (2017-2028)
Figure 37. Global 3D Printing Drug Revenue Market Share by Application (2017-2028)
Figure 38. Global 3D Printing Drug Price by Application (2017-2028) & (US$/Unit)
Figure 39. North America 3D Printing Drug Sales Market Share by Type (2017-2028)
Figure 40. North America 3D Printing Drug Sales Market Share by Application (2017-2028)
Figure 41. North America 3D Printing Drug Sales Market Share by Country (2017-2028)
Figure 42. North America 3D Printing Drug Revenue Market Share by Country (2017-2028)
Figure 43. United States 3D Printing Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada 3D Printing Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico 3D Printing Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe 3D Printing Drug Sales Market Share by Type (2017-2028)
Figure 47. Europe 3D Printing Drug Sales Market Share by Application (2017-2028)
Figure 48. Europe 3D Printing Drug Sales Market Share by Country (2017-2028)
Figure 49. Europe 3D Printing Drug Revenue Market Share by Country (2017-2028)
Figure 50. Germany 3D Printing Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France 3D Printing Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom 3D Printing Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia 3D Printing Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy 3D Printing Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific 3D Printing Drug Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific 3D Printing Drug Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific 3D Printing Drug Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific 3D Printing Drug Revenue Market Share by Region (2017-2028)
Figure 59. China 3D Printing Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan 3D Printing Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea 3D Printing Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India 3D Printing Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia 3D Printing Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia 3D Printing Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America 3D Printing Drug Sales Market Share by Type (2017-2028)
Figure 66. South America 3D Printing Drug Sales Market Share by Application (2017-2028)
Figure 67. South America 3D Printing Drug Sales Market Share by Country (2017-2028)
Figure 68. South America 3D Printing Drug Revenue Market Share by Country (2017-2028)
Figure 69. Brazil 3D Printing Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina 3D Printing Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa 3D Printing Drug Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa 3D Printing Drug Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa 3D Printing Drug Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa 3D Printing Drug Revenue Market Share by Region (2017-2028)
Figure 75. Turkey 3D Printing Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt 3D Printing Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia 3D Printing Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa 3D Printing Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of 3D Printing Drug in 2021
Figure 80. Manufacturing Process Analysis of 3D Printing Drug
Figure 81. 3D Printing Drug Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のゴセレリン薬物市場2022年：市場規模予測（～2028年）
  • 世界の神経線維腫症治療薬市場2022年：市場規模予測（～2028年）
  • 世界のCDK4及び6阻害医薬品市場2022年：市場規模予測（～2028年）
  • 世界のアフリベルセプト薬市場2022年：市場規模予測（～2028年）
  • 世界の軟骨形成術治療薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19089 )"世界の3Dプリンター製医薬品市場2022年：市場規模予測（～2028年）" (英文：Global 3D Printing Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。